Constipation
📧 Sign up to get email alerts when something new happens for Constipation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-14FDA Approved: KRISTALOSE — Supplemental Application (Cumberland Pharmaceuticals Inc.)
The FDA approved a supplemental application for Kristalose (lactulose) from Cumberland Pharmaceuticals Inc.
-
FDA approval · 2026-02-23FDA Approved: SODIUM PHOSPHATES — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approves the original application for Sodium Phosphates from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2025-06-24FDA Approved: PRUCALOPRIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' prucalopride (ANDA 218847) as a generic product for the treatment of chronic constipation in adults.
-
EMA approval · 2025-04-11EMA Authorised: Moventig (naloxegol oxalate) — Grunenthal GmbH
EMA authorised Moventig (naloxegol oxalate) from Grunenthal GmbH for the treatment of constipation, including opioid-induced constipation. T…
-
FDA approval · 2025-03-14FDA Approved: LACTULOSE — Original Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved an original application for lactulose as a generic drug, manufactured by PAI Holdings (dba PAI Pharma).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-12-13FDA Approved: LACTULOSE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a generic lactulose product from Sun Pharmaceutical Industries as an Original Application (ANDA 218858).
-
FDA approval · 2024-10-18FDA Approved: SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for a generic product containing sodium sulfate, potassium sulfate and magnesium s…
-
FDA approval · 2024-09-17FDA Approved: LACTULOSE — Supplemental Application (Xttrium Laboratories, Inc.)
FDA approved a supplemental application for lactulose submitted by Xttrium Laboratories, Inc., authorizing a new generic lactulose product.
-
EMA approval · 2024-09-12EMA Authorised: Resolor (prucalopride succinate) — Takeda Pharmaceuticals International AG Ireland
The European Medicines Agency authorised Resolor (prucalopride succinate) for the treatment of constipation, granting marketing authorizatio…
-
FDA approval · 2024-06-24FDA Approved: SODIUM SULFATE, POTASSIUM SULFATE, AND MAGNESIUM SULFATE — Original Application (Bionpharma Inc.,)
FDA approved an Original Application for a generic saline laxative combining sodium sulfate, potassium sulfate, and magnesium sulfate (Bionp…
-
FDA approval · 2024-06-21FDA Approved: SODIUM PHOSPHATES — Original Application (Civica, Inc.)
FDA approved Civica, Inc.'s Original Application for a generic sodium phosphate product (sodium phosphate monobasic monohydrate and sodium p…
-
FDA approval · 2024-06-12FDA Approved: POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES - UNFLAVORED — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for polyethylene glycol 3350 and electrolytes - unflavored, expanding the product line to include an…
-
FDA approval · 2024-06-06FDA Approved: POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE - UNFLAVORED — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Polyethylene Glycol 3350 with electrolytes to add unflavored and flavored variants (lemon, o…
-
FDA approval · 2024-02-20FDA Approved: LACTULOSE SOLUTION — Supplemental Application (Bajaj Medical, LLC)
FDA approved Bajaj Medical, LLC's supplemental application for Lactulose Solution USP (10 g/15 mL), confirming continued availability of the…
-
FDA approval · 2023-11-22FDA Approved: SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL — Original Application (Strides Pharma Science Limited)
FDA approved an original application for a generic oral combination of sodium sulfate, potassium sulfate and magnesium sulfate.
-
FDA approval · 2023-08-29FDA Approved: CLENPIQ — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approves a supplemental application for CLENPIQ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) submitted by Ferring Ph…
-
FDA approval · 2023-07-27FDA Approved: MIRALAX — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Miralax (polyethylene glycol 3350) from Bayer HealthCare LLC.
-
FDA approval · 2023-06-15FDA Approved: SUFLAVE — Original Application (Braintree Laboratories, Inc.)
The FDA approved SUFLAVE, an oral solution containing polyethylene glycol 3350 with electrolytes for bowel cleansing. This marks an original…
-
FDA approval · 2023-03-23FDA Approved: MIRALAX — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for MIRALAX (polyethylene glycol 3350) by Bayer HealthCare LLC.
-
FDA approval · 2023-02-09FDA Approved: POLYETHYLENE GLYCOL 3350 NF — Supplemental Application (SUNRISE PHARMACEUTICAL, INC)
FDA approved a supplemental application for polyethylene glycol 3350 NF from Sunrise Pharmaceutical, Inc., indicating an approval-related up…
-
FDA approval · 2023-02-08FDA Approved: POLYETHYLENE GLYCOL 3350 — Supplemental Application (Major Pharmaceuticals)
FDA approved a supplemental application for polyethylene glycol 3350 from Major Pharmaceuticals, updating the product’s labeling/indication.…
-
FDA approval · 2022-12-07FDA Approved: POLYETHYLENE GLYCOL 3350 — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for polyethylene glycol 3350 from Aurobindo Pharma Limited, making this generic product available un…
-
FDA approval · 2022-11-02FDA Approved: POLYETHYLENE GLYCOL (3350) — Supplemental Application (Mylan Institutional Inc.)
The FDA approved a supplemental application for polyethylene glycol 3350 submitted by Mylan Institutional Inc.
-
FDA approval · 2022-07-05FDA Approved: MIRALAX — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental NDA for Miralax (polyethylene glycol 3350) filed by Bayer HealthCare LLC., updating the labeling for its approve…
-
FDA approval · 2022-06-16FDA Approved: PURELAX — Supplemental Application (CVS Pharmacy)
The FDA approved a supplemental application for PureLax (polyethylene glycol 3350) submitted by CVS Pharmacy.